Other studies have found that these factors can also affect the prognosis of TNBC, including tumor-infiltrating lymphocytes (TILs), CD103 iTIL density [48], positive prolactin receptor [49], adipophilin [50], erythropoietin receptor [51] and increased Bcl-2 expression [52]. The gene discussed is PRLR; the disease is neoplasm.